• Tomivosertib Suppresses Human DRG Nociceptor Hyperactivity

  2026-07-08

  The reference study provides the first direct evidence that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion (DRG) neurons from radiculopathy patients. These mechanistic findings highlight MNK signaling as a promising translational target for neuropathic pain intervention.

• ABT-888 (Veliparib): Advancing DNA Repair Inhibition in Canc

  2026-07-07

  ABT-888 (Veliparib) from APExBIO empowers researchers to dissect DNA repair mechanisms and potentiate chemotherapy and radiation responses in challenging cancer models. This article details actionable protocols, advanced use-cases in MSI and resistant tumors, and real-world troubleshooting strategies that maximize the impact of this potent PARP1/2 inhibitor.

• Bone Transport Accelerates DFU Healing via TGF-β1 Pathway

  2026-07-07

  This study demonstrates that bone transport (BT) significantly accelerates diabetic foot ulcer (DFU) healing by activating the TGF-β1/TGFBR1 pathway, coupling angiogenesis and osteo-immune modulation. The findings clarify the mechanistic role of TGF-β1 signaling in chronic wound repair, with implications for targeted intervention strategies.

• Cy5 NHS ester(Et): Technical Guide for Protein Fluorescent L

  2026-07-06

  Cy5 NHS ester(Et) provides a water-soluble, amine-reactive fluorescent dye solution for reliable labeling of proteins and other biomolecules in immunofluorescence, flow cytometry, and microscopy. It is not suitable for ethanol-based protocols or for long-term storage of dissolved working solutions. Adhering to recommended dissolution and handling procedures is critical for reproducible results.

• Salvianolic Acid B: Transforming Pulmonary Fibrosis Research

  2026-07-06

  Salvianolic acid B (Dan Shen Suan B) is redefining fibrosis research by enabling targeted inhibition of lysyl hydroxylase 2 (LH2), directly impacting collagen cross-linking and extracellular matrix remodeling. This article guides researchers through advanced workflows, experimental troubleshooting, and practical strategies for maximizing the compound’s unique antifibrotic potential in pulmonary fibrosis models.

• Cy7 NHS Ester: Practical Guide for Near-Infrared Protein Lab

  2026-07-05

  Sulfo-Cy7 NHS Ester addresses challenges in near-infrared labeling of proteins and peptides by offering high water solubility and minimized fluorescence quenching. It is best suited for workflows requiring sensitive, quantitative tracking of biomolecules in biological systems, but is not recommended for long-term storage in solution or for use with strongly denaturing conditions.

• ER Stress–Driven Prometastatic Cell States and Metastasis Or

  2026-07-04

  Conod et al. reveal how tumor cells surviving impending cell death acquire stable prometastatic states (PAMEs), driving distant metastases via ER stress, nuclear reprogramming, and a cytokine storm. Their findings highlight new therapeutic targets and reshape understanding of metastatic initiation in cancer.

• Antimycin A4: Dual Pathway Inhibition and Advanced Assay Des

  2026-07-03

  Explore how Antimycin A4, a potent ATP-citrate lyase inhibitor, enables next-generation metabolic and mitochondrial research. This article uniquely bridges chemical innovation with practical assay optimization, offering new insights beyond standard protocols.

• Anlotinib Hydrochloride: Advancing Multi-Target Angiogenesis

  2026-07-03

  This thought-leadership article explores how Anlotinib hydrochloride, a next-generation multi-target tyrosine kinase inhibitor, is reshaping translational cancer research. Integrating mechanistic insights, comparative efficacy data, and strategic workflow guidance, it addresses key challenges in angiogenesis modeling and clinical translation—offering a roadmap for researchers navigating the evolving landscape of anti-angiogenic therapeutics.

• Z-VDVAD-FMK: Illuminating Caspase-2 Pathways Beyond Apoptosi

  2026-07-02

  Explore how Z-VDVAD-FMK, a potent caspase-2 inhibitor, advances apoptosis research and uncovers new roles for caspases in host-pathogen defense. This article uniquely bridges mechanistic insight from virology with advanced assay design, offering perspectives not found in standard protocol guides.

• Ampicillin Sodium (A2510): Reliable Antibacterial Assays

  2026-07-02

  This article addresses recurring laboratory challenges in cell viability, proliferation, and antibacterial activity assays by presenting scenario-driven solutions centered on Ampicillin sodium (SKU A2510). Drawing on peer-reviewed evidence and direct product data, we demonstrate how precise protocol selection and quality sourcing, such as APExBIO’s high-purity Ampicillin sodium, enable reproducible, sensitive, and efficient research outcomes.

• Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial U

  2026-07-01

  Temafloxacin stands out as a fluoroquinolone broad-spectrum antibacterial agent with superior efficacy against both Gram-positive and Gram-negative bacteria, including challenging respiratory pathogens. This article delivers actionable protocols, troubleshooting guidance, and direct workflow enhancements for researchers leveraging Temafloxacin in advanced infection biology and intracellular bactericidal assays.

• LY2109761: A Dual TGF-β Receptor Inhibitor for Precision Onc

  2026-07-01

  LY2109761 is a highly selective TGF-β receptor type I and II dual inhibitor, empowering researchers to modulate Smad2/3 phosphorylation with precision in cancer and fibrosis models. Its robust, reproducible performance in radiosensitization and anti-tumor workflows sets it apart as an indispensable tool for dissecting TGF-β-driven disease mechanisms.

• JZL184 (SKU B1958): Reliable MAGL Inhibition for Cell Assays

  2026-06-30

  This article provides scenario-driven, evidence-based guidance on using JZL184 (SKU B1958)—a selective monoacylglycerol lipase inhibitor—for robust and reproducible endocannabinoid pathway research. Drawing on real laboratory challenges and recent literature, it details practical protocols and vendor considerations that support reproducibility and data integrity in cell viability, proliferation, and cytotoxicity assays.

• Applied Workflows with Recombinant Human IL-15 for T/NK Cell

  2026-06-30

  Accelerate T and NK cell assays with APExBIO's tag-free Recombinant Human IL-15, validated for high bioactivity and purity. Explore advanced experimental workflows, troubleshooting insights, and the nuanced impact of immune modulation in neurobehavioral models.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page